AGL-2263 structure
|
Common Name | AGL-2263 | ||
---|---|---|---|---|
CAS Number | 638213-98-6 | Molecular Weight | 322.272 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C17H10N2O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of AGL-2263AGL-2263 is an insulin receptor (IR) blocker. |
Name | AGL-2263 |
---|---|
Synonym | More Synonyms |
Description | AGL-2263 is an insulin receptor (IR) blocker. |
---|---|
Related Catalog | |
Target |
Insulin receptor[1]. |
In Vitro | AGL-2263 is an insulin receptor (IR) blocker[1]. |
Cell Assay | Trophoblast cells are prepared from normal or GDM placentas. They are incubated in the presence of stimulants, insulin (100 nM) or both insulin and AGL-2263 (AGL, 5 μM) IR blocker, together for 24 hr[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C17H10N2O5 |
Molecular Weight | 322.272 |
Exact Mass | 322.058960 |
LogP | 1.72 |
Index of Refraction | 1.728 |
Storage condition | 2-8℃ |
(2E)-2-(3,4-Dihydroxybenzoyl)-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)acrylonitrile |
Benzenepropanenitrile, α-[(2,3-dihydro-2-oxo-5-benzoxazolyl)methylene]-3,4-dihydroxy-β-oxo-, (αE)- |